Gida » Duka » Hasashen Hannun Jari » Theravance Biopharma Inc. Ordinary Shares Hasashen

Theravance Biopharma Inc. Ordinary Shares Hasashen: Gobe, Mako, Watan, Shekaru 5

An sabunta: April 22 · 2026 at 07:03 UTC

From

▼ -0.60%Market Cap $855.81M · Technical analysis Bearish · Focus area Price + volatility

Takaitaccen Hasashen

Lokaci	Farashin Hasashen	Baya	Na tarihi	Hankali
Gobe	$16.50 ▼ -0.71%	Jiya	$16.67 ▲ +0.30%	Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.
Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.
Mako	$16.25 ▼ -2.20%	Makon da ya gabata	$16.77 ▲ +0.92%	The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.
The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.
Watan	$15.84 ▼ -4.69%	A watan da ya gabata	$16.95 ▲ +1.97%	The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Shekara	$15.22 ▼ -8.41%	Shekaran da ya gabata	$17.21 ▲ +3.53%	The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
Shekaru 5	$13.77 ▼ -17.14%	Shekaru 5 da suka gabata	$17.82 ▲ +7.20%	The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Gobe$16.50▼ -0.71%

Jiya$16.67▲ +0.30%

Tomorrow's Theravance Biopharma Inc. Ordinary Shares (TBPH) setup is anchored to $16.62 and targets $16.50 (-0.71%). The near-term read is downside; watch $17.12 / $16.12 because daily realized volatility is about 3.65%.

Mako$16.25▼ -2.20%

Makon da ya gabata$16.77▲ +0.92%

The 7-day Theravance Biopharma Inc. Ordinary Shares model moves from $16.77 to $16.25 (-2.20%). It gives downside momentum context for this stock, so breaks around $17.12 / $16.12 matter more than a single tick.

Watan$15.84▼ -4.69%

A watan da ya gabata$16.95▲ +1.97%

The 1-month Theravance Biopharma Inc. Ordinary Shares target is $15.84 (-4.69%), compared with the live reference near $16.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Shekara$15.22▼ -8.41%

Shekaran da ya gabata$17.21▲ +3.53%

The 1-year Theravance Biopharma Inc. Ordinary Shares scenario points to $15.22 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

Shekaru 5$13.77▼ -17.14%

Shekaru 5 da suka gabata$17.82▲ +7.20%

The 5-year Theravance Biopharma Inc. Ordinary Shares view is $13.77 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Jadawalin farashi

Na tarihiHasashenTsananiBearish

Binciken Fasaha

Bearish

Tsanani

tsaka tsaki

Bearish

Maɓallin Maɓalli

Mai nuna alama	Daraja	Sigina
Price	$16.62	Mid
Daily Change	-0.60%	Below
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

Bayanan Tarihi

Current$16.62

Daily Change-0.60%

Market Cap$855.81M

Sourcenasdaq-screener

Current	$16.62	Daily Change	-0.60%
Market Cap	$855.81M	Source	nasdaq-screener

Taimako & Matakan Juriya

$16.12Support 1

$16.62A halin yanzu

$17.12Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Matsalolin Farashi

Mahimmin matakai & mahallin tarihi

Current$16.62Live reference price

Used as the anchor for generated forecast calculations.

Next Month$15.84Model projection-4.69%

Directional scenario based on capped drift.

Daidaiton Hasashen

Yadda samfurin mu ya yi

58%

Jagoranci

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algorithm ɗin mu ana sake daidaita shi mako-mako ta amfani da sabon aikin farashi, tsarin canji, da sigina masu nuni. Daidaito ya bambanta ta hanyar lokaci - gajeren lokaci yana da aminci fiye da tsinkaya na dogon lokaci.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yanayin Zuba Jari

Idan kun saka $1,000 a cikin TBPH a yau

Bullish Scenario

$17.45

+5.00% from current

Farashin Target$17.45

Halin yanayiUpside momentum

Yiwuwa50%

Base Scenario

$15.84

-4.69%

Farashin Target$15.84

Halin yanayiCapped drift

Yiwuwa58%

Bearish Scenario

$15.79

-5.00% from current

Farashin Target$15.79

Halin yanayiVolatility drawdown

Yiwuwa42%

Tushen: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Abubuwan Hasashen

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

Tambayoyin da ake yawan yi

Q What is the Theravance Biopharma Inc. Ordinary Shares (TBPH) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Theravance Biopharma Inc. Ordinary Shares is projected near $16.50 versus the current reference around $16.62. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TBPH?

The weekly Theravance Biopharma Inc. Ordinary Shares model points to $16.25, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Theravance Biopharma Inc. Ordinary Shares 1-month and 1-year targets?

The Theravance Biopharma Inc. Ordinary Shares 1-month target is $15.84 (-4.69%), while the 1-year target is $15.22 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Theravance Biopharma Inc. Ordinary Shares 5-year scenario differ from short-term rows?

The Theravance Biopharma Inc. Ordinary Shares long-horizon scenario sits near $13.77 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TBPH support and resistance zones right now?

For Theravance Biopharma Inc. Ordinary Shares, nearest resistance is around $16.12, while nearest support is around $17.12. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Theravance Biopharma Inc. Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.